Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 1998, p. 1503-1505, Vol. 42, No. 6
Department of Pathology, Hershey Medical
Center, Hershey, Pennsylvania 17033,1 and
Department of Pathology, Case Western Reserve University,
Cleveland, Ohio 441062
Received 24 November 1997/Returned for modification 3 March
1998/Accepted 25 March 1998
Trovafloxacin pneumococcal and staphylococcal postantibiotic
effects (PAEs) were 0.7 to 1.8 and 0.7 to 2.4 h, respectively. For
Escherichia coli and Pseudomonas aeruginosa,
PAEs were 2.4 to 4.4 h. Pneumococcal and staphylococcal
postantibiotic sub-MIC effects (PA-SMEs) (0.4 times the MIC) were 2.3 to 3.7 and 2.4 to >9.2 h, respectively, and E. coli
PA-SMEs (0.3 times the MIC) were 6.8 to >12.0 h. For one P. aeruginosa strain, the PA-SME (0.4 times the MIC) was >10 h; in
the other, rapid bactericidal activity precluded measurement.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Postantibiotic Effect of Trovafloxacin against
Gram-Positive and -Negative Organisms
*
Corresponding author. Mailing address: Department of
Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033. Phone: (717) 531-5113. Fax: (717) 531-7953. E-mail:
pappelbaum{at}psghs.edu.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |